Fed Completed Phase 1 Trials for Olanzapine (DB00334)

Also known as: FED

IndicationStatusPhase
DBCOND0052071 (Fed)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01503424Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed StudyTreatment
NCT01503450Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed ConditionTreatment